RTI-7470-44
| Clinical data | |
|---|---|
| Drug class | Trace amine-associated receptor 1 (TAAR1) antagonist | 
| Identifiers | |
| 
 | |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| Chemical and physical data | |
| Formula | C19H11ClF3N5OS | 
| Molar mass | 449.84 g·mol−1 | 
| 3D model (JSmol) | |
| 
 | |
| 
 | |
RTI-7470-44 is a potent and selective antagonist of the human trace amine-associated receptor 1 (TAAR1) which is used in scientific research. It was discovered in 2022 and is the first potent antagonist of the human TAAR1 to be identified, following the potent mouse TAAR1 inverse agonist EPPTB in 2009.